{
  "pmid": "19427284",
  "abstract": "The neurofibroma cell of origin: SKPs expand the playing field.  Morris ZS(1), McClatchey AI.  Author information: (1)Massachusetts General Hospital Center for Cancer Research and Department of  Pathology, Harvard Medical School, Charlestown, MA 02129, USA.  Comment on     Cell Stem Cell. 2009 May 8;4(5):453-63. doi: 10.1016/j.stem.2009.03.017.  Mounting evidence suggests that stem/progenitor cells may be the cells of origin  for many tumor types. In this issue of Cell Stem Cell, Le et al. (2009)  demonstrate that skin-derived precursors (SKPs) can initiate dermal  neurofibromas and highlight the importance of the microenvironment in the  formation of this complex tumor.  DOI: 10.1016/j.stem.2009.04.010 PMID: 19427284 [Indexed for MEDLINE]",
  "methods": "",
  "introduction": "1. Introduction The tumor predisposition disorder von Recklinghausen's neurofibromatosis type I (NF1) is one of the most common genetic disorders of the nervous system, affecting 1 in 3500 individuals worldwide [ 1 â€“ 4 ]. The disease is caused by mutation in the  NF1  gene (located on chromosome 17q11.2) that encodes the tumor suppressor protein neurofibromin, a GTPase-activating protein (GAP) [ 5 ,  6 ]. Neurofibromas are complex tumors that contain proliferating Schwann-like cells and other local supporting elements of the nerve fibers, as perineurial-like cells, fibroblasts, endothelial cells, pericytes, and vascular smooth muscle cells, as well as infiltration of mast cells [ 7 ]. Although several reports have studied which cell originates this tumor, the present data are somewhat contradictory. In this paper we will address the issue of the cell of origin for dermal neurofibromas to explore if the available data support the cancer stem cell hypothesis. We will discuss recent findings in the light of possible involvement of the so-called skin-derived precursor cells in the aetiopathogenesis of this complex disease.",
  "results": "",
  "discussion": "9. Conclusions In summary, current evidence supports the notion that, at least in murine models, skin-derived precursor cells (SKPs) might be a cell of origin for dermal neurofibromas. It is also conceivable that human SKPs might be the cell of origin of neurofibromas, although formal proof for this is lacking. Isolation of SKPs from human neurofibromas could demonstrate if these dermal multipotent stem cells bear the somatic mutation and whether or not this mutation confers a predisposition to these precursor cells to differentiate into the Schwann cell lineage. Furthermore, isolation of SKPs from healthy skin of NF1 patients could demonstrate if there are SKPs with the somatic mutation, even in areas where the neurofibroma is histologically undetectable. In conclusion, SKPs may become a useful tool for the in vitro study of the neurofibromatosis type 1 syndrome.",
  "fetched_at": "2026-02-16T15:38:26.083967",
  "abstract_length": 749,
  "methods_length": 0,
  "introduction_length": 1136,
  "results_length": 0,
  "discussion_length": 876
}